David Charles Baker - May 14, 2021 Form 4 Insider Report for Vallon Pharmaceuticals, Inc. (GRI)

Role
Chief Executive Officer, Director
Signature
/s/ David Baker
Stock symbol
GRI
Transactions as of
May 14, 2021
Transactions value $
$0
Form type
4
Date filed
5/18/2021, 04:06 PM
Next filing
Mar 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRI Stock Option (Right to Buy) Award $0 +100K $0.00 100K May 14, 2021 Common Stock 100K $3.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests as to 25% of the underlying shares of common stock on the first annual anniversary of the date of grant, then in 12 equal quarterly installments such that the stock option is fully vested on the fourth annual anniversary of the date of grant.